activity American Society of Oncology
2011 - Presentactivity American Society of Hematology
2011 - Presentactivity Yale Stem Cell Transplant QI Committee
2018 - Presentactivity YCC Data Safety Monitoring Committee
2019 - Presentactivity American Society for Blood and Marrow Transplantation
2017 - Presentactivity Post Transplant Maintenance for AML- Controversies in Management
Abstract/SynopsisDefended the concept of post-transplant AML maintenance in modern era
honor DAVID S FISHER Annual Award
activity Advances in Stem Cell Transplantation
activity Transplant and Cell Therapy Updates
Abstract/SynopsisReview of Advances from 2022 Annual American Society of Hematology Meet
activity Impact of Age on Outcomes after CD19 Directed CAR T Cell Therapy for Large B Cell Lymphomas: Real World Experience from the Center for International Blood & Marrow Transplant Research (CIBMTR)
Abstract/SynopsisAxicabtagene ciloleucel (axi-cel) and tisagenlecleucel (tisa-cel) are CD19-directed autologous chimeric antigen receptor (CAR) T-cell (CART) therapies approved for the treatment of adults with relapsed or refractory (R/R) large B-cell lymphoma (LBCL). Less than 25% of patients on the initial registration trials were over the age of 65. Real world data on the survival and toxicity outcomes of older patients receiving CAR T-cell (CART) therapy are limited. We used the CIBMTR registry to study the impact of age on response, survival outcomes and incidence of toxicity after receiving commercial CART.
activity Impact of Post-Remission Consolidation Therapy on Outcomes of Haploidentical Hematopoietic Cell Transplantation for Acute Myelogenous Leukemia
Abstract/SynopsisEvaluated the significance of post remission consolidation chemo in transplant eligible patients.
activity Advances in Transplant and Cell Therapy
activity Yale Cancer Center
I served as a reviewer for Yale Cancer Center Data Safety Monitoring Committee2019 - 2022activity Yale Cancer Center Data Safety Monitoring Committee
Served as reviewer of al clinical trials2019 - 2022activity Transplantation and Cell Therapy
Ad-Hoc Reviewer2021 - 2022activity Advances in Myeloid Disorders
activity Advances in Bone Marrow Transplant
activity YNHH Transfusion Medicine Committee
Under leadership of Dr. Snyder2019 - 2019activity Yale Cancer Center
Under leadership of Dr. Ed Snyder served as reviewer for Hospital Transfusion Medicine Committee2019 - 2019activity Yale New Haven Hospital Transfusion Committee
2018 - 2018